Biểu đồ giá cổ phiếu IKT
IKT Giá
Inhibikase Therapeutics Inc
$1.67
0%
$0
Khi đóng cửa: Jun 12, 16:00:00 GMT-4
$1.7
1.79%
$0.03
Phiên sau giờ: Jun 12, 18:28:53 GMT-4
Quay lại
Inhibikase Therapeutics Inc (IKT) Giá
Thống kê chính
Giá đóng cửa trước
$1.67
Giá mở cửa
$1.68
Phạm vi ngày
$1.66 - $1.71
Phạm vi 52 tuần
$1.33 - $2.26
Khối lượng
423.5K
Khối lượng trung bình
1.5M
Tỷ suất cổ tức
--
EPS (TTM)
-1.15
Vốn hóa thị trường
$224.4M
IKT là gì?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
